Charles Ryhee
Stock Analyst at TD Cowen
(1.99)
# 3,081
Out of 4,966 analysts
23
Total ratings
52.38%
Success rate
2.24%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $72.14 | +10.90% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $11.98 | +16.86% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $681.02 | -4.26% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $159.32 | +6.70% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $9.64 | +512.03% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $149.51 | -51.84% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $7.89 | +2,282.76% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $17.24 | +68.21% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $72.14
Upside: +10.90%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $11.98
Upside: +16.86%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $681.02
Upside: -4.26%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $159.32
Upside: +6.70%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $9.64
Upside: +512.03%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $149.51
Upside: -51.84%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $7.89
Upside: +2,282.76%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $17.24
Upside: +68.21%